Future Watch: Gene & Cell Therapy
A Revolution In Medicine And Healthcare Blog
Current Blog Category: HIV Cure
Raising Awareness for Rare Disease Day
Contributing Author Luke Williams, Sales and Marketing Each year on February 28th we shine a spotlight on rare disease research. There are thousands of rare diseases, and many stem from inheriting a single pathogenic gene. Traditional medicine can make patients comfortable and help ameliorate symptoms,…
Read More
How to Design a Gene Therapy to Target Inherited Diseases
Contributing Author Luke Williams, Sales and Marketing The human genome contains approximately 20,000 protein-coding genes. When read, these genes tell a cell how to make a specific protein, which can then be used to perform a cellular process. Variations on any of these genes can…
Read More
Black Pioneers in Biology Who Ushered Us Into the Genetic Age
Contributing Author Luke Williams, Sales and Marketing Meet the scientists who revolutionized our understanding of biochemistry and reframed the human identity For Black History Month, American Gene Technologies® spotlights four of the many influential Black scientists whose work helped launch the genetic age that is…
Read More
The Biotech Project Podcast Dives into the Passionate Vision of Jeff Galvin
The Biotech Project podcast hosts Scott J Resnik, MBA, NYS EMT-CC, and John Walsh, MD, sit down with American Gene Technologies® founder and CEO Jeff Galvin for a lively and inspiring discussion.Watch the full episode to follow Jeff’s journey as he builds a company that’s…
Read More
American Gene Technologies Celebrates Another Year of Progress
Contributing Author John Vandermosten, Senior Biotechnology Analyst In 2022, the world was collectively compelled to endure a surge in viral outbreaks, the horror of the Russia-Ukraine war and rampant inflation, which has led many to a state of pessimism. But, the dramatic events of 2022 have…
Read More
Phase 1 HIV Clinical Trial Data Published in “Frontiers in Medicine” Journal
Contributing Author Luke Williams, Sales and Marketing American Gene Technologies® (AGT) designed AGT103-T in hopes of functionally curing HIV. The therapeutic is made of the patient’s own T cells which have been enhanced for HIV resistance, and data from the Phase 1 human trial has…
Read More
Gene Therapy Clinical Trial Requirements
Contributing Author John Vandermosten, Senior Biotechnology Analyst Gene Therapy Does It “My Way” In 1990, gene therapy burst onto the world stage with the first clinical trial aimed at a genetic disease. This effort, led by a team at the National Institute of Health, successfully treated…
Read More
ShareTreck Host Interviews Jeff Galvin on The Future of Medicine
Raj Natarajan, host of ShareTreck, goes behind the scenes with Jeff Galvin, Founder and CEO of American Gene™ in this compelling interview learn how gene therapy works, and what it means for people with deadly diseases, as well as how it will impact the current…
Read More
The Future of Gene Therapy
Contributing Author John Vandermosten, Senior Biotechnology Analyst Economies of scale can apply to gene therapy too Gene therapy’s advantage is its ability to modify the genetic cause of disease. The approach has the potential to correct genetic errors, cure genetic disease and fight serious infections using…
Read More
Monkeypox: Separating Fact from Fiction
Contributing Author John Vandermosten, Senior Biotechnology Analyst With almost three years of COVID consuming our lives, a reprieve from viral outbreaks seemed deserved. However, that was not to be. A new virulent pathogen known as monkeypox emerged surprisingly quickly earlier this year. In May 2022, a…
Read MoreSubscribe to Receive our Blog Updates
Subscribe to our blog updates to be notified when we release new content!
